Toroso Investments LLC Grows Stake in HCA Healthcare, Inc. (NYSE:HCA)

Toroso Investments LLC lifted its position in HCA Healthcare, Inc. (NYSE:HCA) by 90.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,019 shares of the company’s stock after buying an additional 6,180 shares during the period. Toroso Investments LLC’s holdings in HCA Healthcare were worth $3,433,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. James Investment Research Inc. bought a new position in HCA Healthcare in the 1st quarter worth $31,000. Concord Wealth Partners raised its holdings in HCA Healthcare by 54.1% during the first quarter. Concord Wealth Partners now owns 151 shares of the company’s stock valued at $40,000 after acquiring an additional 53 shares during the period. Covestor Ltd raised its holdings in HCA Healthcare by 122.7% during the first quarter. Covestor Ltd now owns 167 shares of the company’s stock valued at $42,000 after acquiring an additional 92 shares during the period. Osterweis Capital Management Inc. bought a new stake in HCA Healthcare during the fourth quarter valued at about $44,000. Finally, Scissortail Wealth Management LLC bought a new stake in HCA Healthcare during the first quarter valued at about $315,475,000. 62.73% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently issued reports on HCA. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Tuesday. VNET Group reaffirmed a “maintains” rating on shares of HCA Healthcare in a report on Wednesday, June 28th. Oppenheimer lifted their target price on HCA Healthcare from $310.00 to $315.00 and gave the stock an “outperform” rating in a report on Friday, July 28th. Barclays lifted their price target on HCA Healthcare from $275.00 to $300.00 in a research report on Wednesday, June 28th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $315.00 price target on shares of HCA Healthcare in a research report on Thursday. Two investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $310.86.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $263.63 on Friday. The company has a market capitalization of $71.70 billion, a PE ratio of 12.97, a P/E/G ratio of 1.40 and a beta of 1.60. HCA Healthcare, Inc. has a fifty-two week low of $178.32 and a fifty-two week high of $304.86. The company has a debt-to-equity ratio of 79.26, a quick ratio of 1.03 and a current ratio of 1.20. The company has a 50 day moving average price of $277.74 and a 200-day moving average price of $273.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Thursday, July 27th. The company reported $4.29 EPS for the quarter, topping analysts’ consensus estimates of $4.28 by $0.01. The company had revenue of $15.86 billion during the quarter, compared to the consensus estimate of $15.63 billion. HCA Healthcare had a net margin of 9.32% and a negative return on equity of 12,765.76%. HCA Healthcare’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $4.21 earnings per share. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 18.44 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 15th will be given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date of this dividend is Thursday, September 14th. HCA Healthcare’s payout ratio is presently 11.81%.

Insider Transactions at HCA Healthcare

In other news, SVP Kathleen M. Whalen sold 2,916 shares of the company’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $270.00, for a total transaction of $787,320.00. Following the transaction, the senior vice president now directly owns 10,250 shares of the company’s stock, valued at $2,767,500. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, SVP Kathleen M. Whalen sold 2,916 shares of the business’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $270.00, for a total transaction of $787,320.00. Following the sale, the senior vice president now directly owns 10,250 shares of the company’s stock, valued at $2,767,500. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Kathryn A. Torres sold 5,204 shares of the business’s stock in a transaction on Monday, August 14th. The shares were sold at an average price of $269.12, for a total transaction of $1,400,500.48. Following the sale, the senior vice president now directly owns 19,760 shares in the company, valued at $5,317,811.20. The disclosure for this sale can be found here. Over the last three months, insiders have sold 9,620 shares of company stock valued at $2,592,820. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.